Breast cancer, Targeted Protein Degradation, MZ1 PROTAC, JQ1 BET-I, Tuna gelatin hydrogel formulation
heteroscorpionate ligands, Triple negative breast cancer, UNICAM-1, RAPTA-C, therapeutic agents screening, preclinical studies
Nanomedicine, Triple-Negative Breast Cancer, BRCA-mutated tumors, PARP inhibitor, BET inhibitor, Combination Therapy, Drug synergy, Co-delivery
Nanothermometer, Aggregation Induced Emission, Living Systems, Breast Cancer, Fluorescence Lifetime Imaging Micros-copy, Anthracene Aggregates
Carbon Dioxide Utilization, Biogenic Carbon Dioxide, Biogenic ammonia, Sustainable Economy, PM2.5 reduction.
head and neck cancer, liposomes, therapy, cisplatin, alpelisib, active targeting
